News
Bristol Myers Squibb Receives Approval for Abecma, the First CAR T Therapy Approved for the Treatment of Multiple Myeloma in Japan
Bristol-Myers Squibb announced that Japan’s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene vicleucel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor...
Drug Research
TrakCel and Korber partner to provide orchestration within manufacturing of cell and gene therapies
TrakCel, a leading supplier of cellular orchestration solutions for the cell and gene therapy industry, announces it is launching a software integration resulting from...
Press Releases
Sterling Pharma Solutions Expands Early Phase Development Capabilities at Cary
Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced that it has commenced a $2.1 million expansion project to increase chemical and...
Drug Research
West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced an exclusive supply and technology agreement with Corning Incorporated....
Drug Research
Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
Evotec SE announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic...
Drug Research
Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell -based disease...
News
Ashfield Engage bolsters patient solutions offering in Canada with Medaxis acquisition
Ashfield Engage, part of UDG Healthcare, has announced the acquisition of Medaxis, a patient engagement services partner for the life sciences industry, providing services...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read